We are live on ! Find out more
MLL

Moody Lynn & Lieberson Portfolio holdings

AUM $1.9B
1-Year Est. Return 27.82%
This Fund
S&P 500
This Quarter Est. Return
-3.22%
1 Year Est. Return
+27.82%
3 Year Est. Return
+128.03%
5 Year Est. Return
+198.12%
10 Year Est. Return
+974.77%
AUM
$1.04B
AUM Growth
-$74.8M
Cap. Flow
-$1.02B
Cap. Flow %
-98.71%
Top 10 Hldgs %
30.61%
Holding
232
New
13
Increased
34
Reduced
92
Closed
16

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$14.6M
2
TEAM icon
Atlassian
TEAM
+$9.28M
3
NEE icon
NextEra Energy
NEE
+$8.3M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.2M
5
A icon
Agilent Technologies
A
+$4M

Sector Composition

Rank Sector Weight
1 Technology 22.88%
2 Healthcare 21.94%
3 Financials 14.33%
4 Industrials 11.15%
5 Consumer Staples 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAR icon
51
Marriott International
MAR
$92.3B
$4.61M 0.45%
32,900
-413
-1% -$63.1K
COST icon
52
Costco
COST
$420B
$4.59M 0.44%
9,718
+5,731
+144% +$2.98M
AMT icon
53
American Tower
AMT
$80.4B
$4.29M 0.41%
19,997
-3,379
-14% -$868K
ADP icon
54
Automatic Data Processing
ADP
$108B
$4.25M 0.41%
18,790
-49
-0.3% -$11.6K
WRB icon
55
W.R. Berkley
WRB
$26.6B
$4.13M 0.4%
95,888
+5,360
+6% +$233K
DHR icon
56
Danaher
DHR
$144B
$4.05M 0.39%
17,711
+8,898
+101% +$2.18M
GPC icon
57
Genuine Parts
GPC
$18.7B
$3.92M 0.38%
26,287
+15,180
+137% +$2.29M
MCK icon
58
McKesson
MCK
$101B
$3.92M 0.38%
11,519
+100
+0.9% +$34.7K
GD icon
59
General Dynamics
GD
$106B
$3.8M 0.37%
17,909
+135
+0.8% +$30.5K
A icon
60
Agilent Technologies
A
$41.2B
$3.79M 0.37%
+31,183
New +$4M
NBIX icon
61
Neurocrine Biosciences
NBIX
$16.6B
$3.68M 0.36%
34,680
-5
-0% -$507
ANET icon
62
Arista Networks
ANET
$238B
$3.64M 0.35%
129,092
+90,940
+238% +$2.62M
RTX icon
63
RTX Corp
RTX
$301B
$3.62M 0.35%
44,253
-35,038
-44% -$3.17M
CDNS icon
64
Cadence Design Systems
CDNS
$93.4B
$3.11M 0.3%
+19,050
New +$3.28M
SNPS icon
65
Synopsys
SNPS
$79.7B
$3.04M 0.29%
+9,950
New +$3.37M
REGN icon
66
Regeneron Pharmaceuticals
REGN
$80.8B
$2.94M 0.28%
4,274
-3,387
-44% -$2.13M
MDLZ icon
67
Mondelez International
MDLZ
$79.9B
$2.78M 0.27%
50,708
-41,517
-45% -$2.58M
RPRX icon
68
Royalty Pharma
RPRX
$25.3B
$2.74M 0.26%
68,165
+37,320
+121% +$1.59M
VTI icon
69
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$2.72M 0.26%
15,177
+33
+0.2% +$6.58K
XOM icon
70
ExxonMobil
XOM
$634B
$2.69M 0.26%
30,851
-4,132
-12% -$377K
BJ icon
71
BJs Wholesale Club
BJ
$12.3B
$2.68M 0.26%
36,759
+30,690
+506% +$2.2M
IDXX icon
72
Idexx Laboratories
IDXX
$46.2B
$2.65M 0.26%
8,124
META icon
73
Meta Platforms (Facebook)
META
$1.51T
$2.64M 0.25%
19,464
-8,164
-30% -$1.32M
AES icon
74
AES
AES
$10.5B
$2.54M 0.24%
+112,265
New +$2.66M
PLUG icon
75
Plug Power
PLUG
$3.04B
$2.49M 0.24%
+118,435
New +$2.82M

Similar funds

Moody Lynn & Lieberson's Q3 2022 Portfolio in Review

As of Q3 2022, Moody Lynn & Lieberson held 232 positions worth $1.04B, down 6.7% from $1.11B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Moody Lynn & Lieberson withdrew a net $1.02B in Q3 2022, closing 16 positions and reducing 92 holdings. Its most notable exit was AstraZeneca, an estimated $5.63M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Moody Lynn & Lieberson opened a new position in Uber worth $14M.

  • Moody Lynn & Lieberson's largest Q3 2022 buy was Uber: 529,300 shares worth $14M.
  • Moody Lynn & Lieberson added most to Atlassian in Q3 2022, an estimated $9.28M increase.
  • Moody Lynn & Lieberson's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $895M.
  • Moody Lynn & Lieberson fully exited AstraZeneca in Q3 2022, selling an estimated $5.63M.
  • Moody Lynn & Lieberson's ten largest holdings make up 31% of its $1.04B portfolio in Q3 2022.
  • Moody Lynn & Lieberson opened 13 new positions and closed 16 in Q3 2022.
  • Moody Lynn & Lieberson's portfolio value fell 6.7% quarter-over-quarter to $1.04B.

Based on Moody Lynn & Lieberson's 13F filing for Q3 2022, filed 26 Oct 2022.